Stay updated on Belantamab Mafodotin Combo in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab Mafodotin Combo in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Mafodotin Combo in Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The DREAMM 9 study record now indicates that results are posted, with sections for participant flow, baseline characteristics, outcome measures, and adverse events. A new record version dated 2026-11-06 was added.
    Difference
    0.9%
    Check dated 2026-11-15T12:50:10.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T13:24:44.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The DREAMM 9 record now lists a second results submission event, indicating additional results-reporting activity. An NIH notice about the transition from “AI” to “SI” also appears.
    Difference
    0.5%
    Check dated 2026-10-25T13:08:10.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2, while the study record information remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-18T14:27:37.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T14:57:22.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) has been added to the record history, replacing the previous revision (v3.6.6). This signals an update to the page history, typically reflecting refreshed or corrected content in the study record.
    Difference
    0.1%
    Check dated 2026-09-20T11:20:03.000Z thumbnail image

Stay in the know with updates to Belantamab Mafodotin Combo in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin Combo in Myeloma Clinical Trial page.